Under the same experimental conditions, we found that 2i treatment did not cause a significant reduction of UHRF1 or DNMT1 proteins in LNCaP (prostate cancer), Bel7402, C33A and SiHa (cervical cancer) cells (Fig. 2e). Here, UHRF1 is linked to prostate carcinoma.